Assess whether regulatory approval is a timing risk or a deal risk (323af4)

SITUATION In a roll-up of three regional service companies, carve-out stranded-cost model is the evidence after a Phase II that found groundwater impact. Buy-side QoE lead has to pick Regulatory approval is a timing risk or A deal risk for this M&A Due Diligence People and Contracts close using carve-out stranded-cost model.

DECISION Buy-side QoE lead in a roll-up of three regional service companies must choose Regulatory approval is a timing risk / A deal risk using carve-out stranded-cost model after a Phase II that found groundwater impact.

HYPOTHESES TO TEST 1. Buy-side QoE lead can defend Regulatory approval is a timing risk from carve-out stranded-cost model after a Phase II that found groundwater impact in a M&A Due Diligence challenge. 2. Buy-side QoE lead cannot defend Regulatory approval is a timing risk from carve-out stranded-cost model; A deal risk is what the extract actually supports after a Phase II that found groundwater impact. 3. A Phase II that found groundwater impact never reached the population in carve-out stranded-cost model — reopen intake, do not close regulatory approval is a. 4. Two facts in carve-out stranded-cost model after a Phase II that found groundwater impact conflict for buy-side QoE lead; hold this People and Contracts file.

ANALYSIS REQUIRED 1. Name the document buy-side QoE lead still needs before signing. 2. Test whether a Phase II that found groundwater impact is a diligence gap, a price chip, or a walk-away. 3. Separate a one-off add-back from a recurring earnings issue in carve-out stranded-cost model. 4. For this M&A Due Diligence People and Contracts file, read carve-out stranded-cost model against a Phase II that found groundwater impact and write the one fact that would move regulatory approval is a for buy-side QoE lead.

RECOMMENDATION Choose Regulatory approval is a timing risk / A deal risk on this M&A Due Diligence / People and Contracts packet (carve-out stranded-cost model after a Phase II that found groundwater impact). Lead with the M&A Due Diligence option carve-out stranded-cost model can support after a Phase II that found groundwater impact, then the two facts that force it, then the Monday action for buy-side QoE lead in a roll-up of three regional service companies.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on regulatory approval is a, then the evidence in carve-out stranded-cost model, then the action for buy-side QoE lead - Hypothesis scorecard against carve-out stranded-cost model: supported / rejected / untestable - Named option among Regulatory approval is a timing risk, A deal risk and the fact that kills the others - Owner and next date for buy-side QoE lead in a roll-up of three regional service companies